Standard Chemical & Pharmaceutical Co. Ltd. (TPE: 1720)
Taiwan
· Delayed Price · Currency is TWD
60.90
0.00 (0.00%)
Jan 20, 2025, 1:30 PM CST
Standard Chemical & Pharmaceutical Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Revenue | 6,708 | 6,240 | 5,851 | 4,604 | 4,305 | 3,937 | Upgrade
|
Revenue Growth (YoY) | 7.66% | 6.64% | 27.09% | 6.94% | 9.35% | 10.19% | Upgrade
|
Cost of Revenue | 3,769 | 3,514 | 3,364 | 2,536 | 2,386 | 2,228 | Upgrade
|
Gross Profit | 2,939 | 2,725 | 2,488 | 2,068 | 1,920 | 1,709 | Upgrade
|
Selling, General & Admin | 1,279 | 1,209 | 1,100 | 948.47 | 992.48 | 973.56 | Upgrade
|
Research & Development | 284.06 | 266.27 | 251.88 | 241.79 | 227.21 | 225.77 | Upgrade
|
Operating Expenses | 1,571 | 1,466 | 1,369 | 1,191 | 1,213 | 1,194 | Upgrade
|
Operating Income | 1,368 | 1,260 | 1,118 | 876.83 | 706.63 | 515.59 | Upgrade
|
Interest Expense | -19.02 | -25.42 | -18.78 | -7.25 | -7.57 | -10.47 | Upgrade
|
Interest & Investment Income | 61.2 | 76.84 | 39.45 | 24.99 | 26.52 | 30.73 | Upgrade
|
Earnings From Equity Investments | 2.67 | 41.56 | 61.37 | -6.16 | 3.05 | 1.75 | Upgrade
|
Currency Exchange Gain (Loss) | -3.14 | 5.62 | 170.44 | -25.6 | -33.07 | -28.93 | Upgrade
|
Other Non Operating Income (Expenses) | 42.71 | 30.1 | 35.44 | 77.66 | 77.29 | 89.36 | Upgrade
|
EBT Excluding Unusual Items | 1,452 | 1,388 | 1,406 | 940.47 | 772.85 | 598.03 | Upgrade
|
Gain (Loss) on Sale of Investments | 5.37 | 5.53 | 1.36 | 1.46 | 0.2 | -3.46 | Upgrade
|
Gain (Loss) on Sale of Assets | -3.48 | 1.27 | -7.78 | 73.78 | -0.08 | -9.02 | Upgrade
|
Asset Writedown | - | - | - | -1.81 | - | - | Upgrade
|
Other Unusual Items | -0.06 | 0.02 | 0.11 | -66.45 | -0.04 | 0.26 | Upgrade
|
Pretax Income | 1,529 | 1,438 | 1,400 | 1,014 | 772.93 | 585.81 | Upgrade
|
Income Tax Expense | 314.89 | 279.94 | 246.31 | 176.95 | 147.37 | 115.38 | Upgrade
|
Earnings From Continuing Operations | 1,214 | 1,158 | 1,154 | 836.8 | 625.56 | 470.43 | Upgrade
|
Net Income to Company | 1,214 | 1,158 | 1,154 | 836.8 | 625.56 | 470.43 | Upgrade
|
Minority Interest in Earnings | -366.91 | -323.04 | -338.21 | -130.07 | -101.39 | -93.95 | Upgrade
|
Net Income | 847.58 | 834.89 | 815.41 | 706.73 | 524.17 | 376.48 | Upgrade
|
Net Income to Common | 847.58 | 834.89 | 815.41 | 706.73 | 524.17 | 376.48 | Upgrade
|
Net Income Growth | -0.06% | 2.39% | 15.38% | 34.83% | 39.23% | 0.57% | Upgrade
|
Shares Outstanding (Basic) | 179 | 179 | 179 | 179 | 179 | 179 | Upgrade
|
Shares Outstanding (Diluted) | 179 | 179 | 179 | 179 | 179 | 179 | Upgrade
|
Shares Change (YoY) | -0.01% | 0.00% | -0.02% | 0.02% | 0.01% | -0.01% | Upgrade
|
EPS (Basic) | 4.74 | 4.67 | 4.56 | 3.95 | 2.93 | 2.11 | Upgrade
|
EPS (Diluted) | 4.74 | 4.67 | 4.56 | 3.95 | 2.93 | 2.10 | Upgrade
|
EPS Growth | -0.00% | 2.41% | 15.44% | 34.81% | 39.52% | 0.48% | Upgrade
|
Free Cash Flow | 1,083 | 710.83 | 31.78 | 613.56 | 570.06 | 474.71 | Upgrade
|
Free Cash Flow Per Share | 6.05 | 3.97 | 0.18 | 3.43 | 3.19 | 2.65 | Upgrade
|
Dividend Per Share | 2.700 | 2.700 | 2.500 | 2.500 | 1.800 | 1.500 | Upgrade
|
Dividend Growth | 8.00% | 8.00% | 0% | 38.89% | 20.00% | 0% | Upgrade
|
Gross Margin | 43.81% | 43.68% | 42.51% | 44.91% | 44.59% | 43.41% | Upgrade
|
Operating Margin | 20.39% | 20.19% | 19.11% | 19.04% | 16.41% | 13.10% | Upgrade
|
Profit Margin | 12.63% | 13.38% | 13.94% | 15.35% | 12.17% | 9.56% | Upgrade
|
Free Cash Flow Margin | 16.14% | 11.39% | 0.54% | 13.33% | 13.24% | 12.06% | Upgrade
|
EBITDA | 1,732 | 1,579 | 1,389 | 1,073 | 917.22 | 722.14 | Upgrade
|
EBITDA Margin | 25.81% | 25.30% | 23.74% | 23.31% | 21.30% | 18.34% | Upgrade
|
D&A For EBITDA | 363.68 | 319.44 | 270.67 | 196.31 | 210.59 | 206.56 | Upgrade
|
EBIT | 1,368 | 1,260 | 1,118 | 876.83 | 706.63 | 515.59 | Upgrade
|
EBIT Margin | 20.39% | 20.19% | 19.11% | 19.04% | 16.41% | 13.10% | Upgrade
|
Effective Tax Rate | 20.59% | 19.47% | 17.59% | 17.45% | 19.07% | 19.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.